DE602004031092D1 - Virulentes systemisches felines calicivirus - Google Patents

Virulentes systemisches felines calicivirus

Info

Publication number
DE602004031092D1
DE602004031092D1 DE602004031092T DE602004031092T DE602004031092D1 DE 602004031092 D1 DE602004031092 D1 DE 602004031092D1 DE 602004031092 T DE602004031092 T DE 602004031092T DE 602004031092 T DE602004031092 T DE 602004031092T DE 602004031092 D1 DE602004031092 D1 DE 602004031092D1
Authority
DE
Germany
Prior art keywords
calicivirus
felines
virulent
fcv
virulent systemic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004031092T
Other languages
English (en)
Inventor
Janet E Foley
Kate Hurley
Niels C Pedersen
Amy Poland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Priority claimed from PCT/US2004/007677 external-priority patent/WO2004083390A2/en
Publication of DE602004031092D1 publication Critical patent/DE602004031092D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16061—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE602004031092T 2003-03-14 2004-03-12 Virulentes systemisches felines calicivirus Expired - Lifetime DE602004031092D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/388,837 US7309495B2 (en) 2003-03-14 2003-03-14 Hemorrhagic feline calicivirus
US10/769,531 US7264816B2 (en) 2003-03-14 2004-01-30 Virulent systemic feline calicivirus
PCT/US2004/007677 WO2004083390A2 (en) 2003-03-14 2004-03-12 Virulent systemic feline calicivirus

Publications (1)

Publication Number Publication Date
DE602004031092D1 true DE602004031092D1 (de) 2011-03-03

Family

ID=32962139

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004031092T Expired - Lifetime DE602004031092D1 (de) 2003-03-14 2004-03-12 Virulentes systemisches felines calicivirus

Country Status (10)

Country Link
US (3) US7309495B2 (de)
EP (1) EP2301574A1 (de)
JP (1) JP4724112B2 (de)
AT (1) ATE495758T1 (de)
CY (1) CY1111521T1 (de)
DE (1) DE602004031092D1 (de)
DK (1) DK1606391T3 (de)
ES (1) ES2358798T3 (de)
NZ (1) NZ541449A (de)
PT (1) PT1606391E (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7306807B2 (en) * 2004-09-13 2007-12-11 Wyeth Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease
GB0603749D0 (en) * 2006-02-24 2006-04-05 Moving Sun Ltd Immune system stimulant and process of manufacturing the same
KR20100038323A (ko) * 2007-05-30 2010-04-14 와이어쓰 엘엘씨 고양이 항원의 유전자를 발현하는 라쿤 폭스바이러스
US10188725B2 (en) 2015-12-14 2019-01-29 Elanco Us Inc. Hybrid core feline vaccines
RU2628096C1 (ru) * 2016-06-01 2017-08-14 Федеральное государственное бюджетное учреждение науки Сибирский федеральный научный центр агробиотехнологий Российской академии наук (СФНЦА РАН) Штамм Эшли вируса калицивироза кошек для изучения противовирусной активности препаратов в отношении калицивироза кошек
US11167027B2 (en) 2017-11-06 2021-11-09 Intervet Inc. Multivalent feline vaccine
WO2019110213A1 (en) 2017-12-08 2019-06-13 Intervet International B.V. Feline calicivirus vaccine
EP3706790A1 (de) 2017-11-06 2020-09-16 Intervet International B.V. Multivalenter impfstoff für katzen
AU2018383915B9 (en) 2017-12-15 2023-06-01 Intervet International B.V. Multivalent feline vaccine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3944469A (en) * 1974-11-21 1976-03-16 Pitman-Moore, Inc. Feline calicivirus vaccine and production thereof
US3937812A (en) * 1974-11-21 1976-02-10 Pitman-Moore, Inc. Feline calicivirus vaccine and production thereof
US3992520A (en) * 1974-11-27 1976-11-16 Merck & Co., Inc. Anti-fertility vaccine comprising solubilized zona pellucida and anti-serum
US4522810A (en) * 1982-12-09 1985-06-11 The Regents Of The University Of California Feline calicivirus vaccine
US4795634A (en) * 1986-03-14 1989-01-03 Aphton Corporation Method for contraception by immunization against the zona pellucida
US5641487A (en) * 1989-06-12 1997-06-24 The Government Of The United States Of America As Represented By The Secretary Department Of Health And Human Services Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides
US5718901A (en) * 1989-07-21 1998-02-17 Pharmacia & Upjohn Company Feline calicivirus gene
ATE193725T1 (de) * 1992-02-28 2000-06-15 Chemo Sero Therapeut Res Inst Anti-felincalicivirus rekombinanter antikörper und dafür kodierendes gen
DE69333610D1 (de) * 1992-11-09 2004-10-07 Zonagen Inc Methoden für die immunoempfängnisverhütung
US6231863B1 (en) * 1997-06-10 2001-05-15 American Cyanamid Company DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same
WO2000076538A1 (en) * 1999-06-10 2000-12-21 Michigan State University Feline calicivirus isolated from cat urine and vaccines thereof

Also Published As

Publication number Publication date
ES2358798T3 (es) 2011-05-13
US20080063663A1 (en) 2008-03-13
ATE495758T1 (de) 2011-02-15
PT1606391E (pt) 2011-04-01
US20040180064A1 (en) 2004-09-16
US7264816B2 (en) 2007-09-04
NZ541449A (en) 2009-01-31
US20040259225A1 (en) 2004-12-23
JP4724112B2 (ja) 2011-07-13
CY1111521T1 (el) 2014-02-12
US7449323B2 (en) 2008-11-11
EP2301574A1 (de) 2011-03-30
JP2006524503A (ja) 2006-11-02
DK1606391T3 (da) 2011-03-21
US7309495B2 (en) 2007-12-18

Similar Documents

Publication Publication Date Title
WO2006031795A8 (en) Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease
NO345071B1 (no) Farmasøytisk preparat og anvendelse derav
CY1117963T1 (el) Αντισωματα που προσδενουν τα il-17a και il-17f
ATE451119T1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
CY1111521T1 (el) Λοιμογονος συστηματικος καλυκοϊος αιλουροειδων
MA29406B1 (fr) Vaccin toxoide alpha de c. perfringens
NO20015073L (no) Vaksiner
DK1881845T3 (da) Nipah-virusvacciner
ATE521621T1 (de) Cpg-einzelstrang-desoxynukleotide zur verwendung als adjuvans
CY1112575T1 (el) Βελτιωμενα αδρανοποιημενα εμβολια fcv
AR056712A1 (es) Composicion y vacuna efectiva para tratar prevenir o mejorar la inoculacion del virus de la influenza canina metodo pra generar un inmunogen del virus dela influenza equina o del virus de la influenza canina modelo de la inoculacion util para determinar la eficacia de la composicion contra el virus
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
AR047581A1 (es) Vacunas de calicivirus felino
DE60115051D1 (de) Immunologische adjuvans verbindungen
RU2020109137A (ru) Вакцина для защиты от streptococcus suis
WO2004083390A3 (en) Virulent systemic feline calicivirus
DK1657248T3 (da) Vaccine til forebyggelse og behandling af svine-progressiv atrofisk rhinitis
DK2050463T3 (da) Vaccinesammensætning til vaccination af hunde mod hundeinfektiøs respiratorisk sygdom (CIRD)
ATE359815T1 (de) Streptococcus-phocae-vakzine
NO20060395L (no) Antigenholdig dyrevaksine
WO2004043286A3 (en) Use of rmlt as a marker antigen for vaccines and as a synergistic adjuvant with amphigen
ATE431745T1 (de) Ltb4 als adjuvans für impfstoffe
AU2003294192A8 (en) Inclusion bodies as antigens for the oral vaccination of animals
ES2172482B1 (es) Adicion de la patente es200100402 "vacuna para la proteccion de perros frente a la leishmania".
CY1116907T1 (el) Ανασυνδυασμενα εμβολια κατα κωπηποδων καλιγιδων (θαλασσιων ψειρων) και αλληλουχιες αντιγονων αυτων